Biomineralized Bacterial Outer Membrane Vesicles Potentiate Safe and Efficient Tumor Microenvironment Reprogramming for Anticancer Therapy
The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Abstract
The highly immunosuppressive tumor microenvironment (TME) in solid tumors often dampens the efficacy of immunotherapy. In this study, bacterial outer membrane vesicles (OMVs) are demonstrated as powerful immunostimulants for TME reprogramming. To overcome the obstacles of antibody‐dependent clearance and high toxicity induced by OMVs upon intravenous injection (a classic clinically relevant delivery mode), calcium phosphate (CaP) shells are employed to cover the surface of OMVs, which enables potent OMV‐based TME reprograming without side effects. Meanwhile, the pH‐sensitive CaP shells facilitate the neutralization of acidic TME, leading to highly beneficial M2‐to‐M1 polarization of macrophages for improved antitumor effect. Moreover, the outer shells can be integrated with functional components like folic acid or photosensitizer agents, which facilitates the use of the OMV‐based platform in combination therapies for a synergic therapeutic effect.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“OMVs with calcium phosphate (CaP) shells promoted cytotoxic T cell infiltration and M2 to M1 macrophage polarization, effectively improving the immunosuppressive TME [123] (Fig. 5H).”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · doi:10.1186/s13045-022-01273-9 · cites this paper as [123]
Citations
Cites
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
Hodi, F. S., O'Day, S. J., McDermott, D. F., Weber, R. W., Sosman, J. A., Haanen, J. B., Gonzalez, R., Robert, C., Schadendorf, D., Hassel, J. C., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003466 · Cited by 15,155
Innate and adaptive immune cells in the tumor microenvironment
Gajewski, T. F., Schreiber, H., & Fu, Y.-X. (2013) · Nature Immunology · doi:10.1038/ni.2703 · Cited by 4,148
Cancer immunotherapy comes of age
Mellman, I., Coukos, G., & Dranoff, G. (2011) · Nature · doi:10.1038/nature10673 · Cited by 3,893
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Galon, J., & Bruni, D. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-018-0007-y · Cited by 3,409
Cytokine Storm in a Phase 1 Trial of the Anti-CD28 Monoclonal Antibody TGN1412
Suntharalingam, G., Perry, M. R., Ward, S., Brett, S. J., Castello-Cortes, A., Brunner, M. D., & Panoskaltsis, N. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa063842 · Cited by 2,164
Couzin-Frankel, J. (2013) · Science · doi:10.1126/science.342.6165.1432 · Cited by 2,051
Thommen, D. S., & Schumacher, T. N. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.03.012 · Cited by 1,299
Molecular tectonics in biomineralization and biomimetic materials chemistry
Mann, S. (1993) · Nature · doi:10.1038/365499a0 · Cited by 1,165
Rodell, C. B., Arlauckas, S. P., Cuccarese, M. F., Garris, C. S., Li, R., Ahmed, M. S., Kohler, R. H., Pittet, M. J., & Weissleder, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0236-8 · Cited by 1,099
Macrophage Regulation of Tumor Responses to Anticancer Therapies
De Palma, M., & Lewis, C. E. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.02.013 · Cited by 1,079
Research works printed but not linked: 1
- Schwechheimer C., 2015, Nat. Rev. Immunol., 13, 605
Cited by
Inorganic nanomaterials with rapid clearance for biomedical applications
Wang, X., Zhong, X., Li, J., Liu, Z., & Cheng, L. (2021) · Chemical Society Reviews · doi:10.1039/d0cs00461h · Cited by 509
Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies
(2022) · doi:10.1186/s13045-022-01273-9 · Cited by 495
“OMVs with calcium phosphate (CaP) shells promoted cytotoxic T cell infiltration and M2 to M1 macrophage polarization, effectively improving the immunosuppressive TME [123] (Fig.”
BackgroundSelf-citationRecent applications of immunomodulatory biomaterials for disease immunotherapy
Dai, H., Fan, Q., & Wang, C. (2022) · Exploration · doi:10.1002/exp.20210157 · Cited by 268
Bioactive inorganic nanomaterials for cancer theranostics
Pei, Z., Lei, H., & Cheng, L. (2023) · Chemical Society Reviews · doi:10.1039/d2cs00352j · Cited by 255
Nanomaterials in tumor immunotherapy: new strategies and challenges
Zhu, X., & Li, S. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01797-9 · Cited by 251
Li, Z., Wang, Y., Liu, J., Rawding, P., Bu, J., Hong, S., & Hu, Q. (2021) · Advanced Materials · doi:10.1002/adma.202102580 · Cited by 244
The tremendous biomedical potential of bacterial extracellular vesicles
Xie, J., Li, Q., Haesebrouck, F., Van Hoecke, L., & Vandenbroucke, R. E. (2022) · Trends in Biotechnology · doi:10.1016/j.tibtech.2022.03.005 · Cited by 240
Feng, Q., Ma, X., Cheng, K., Liu, G., Li, Y., Yue, Y., Liang, J., Zhang, L., Zhang, T., Wang, X., et al. (2022) · Advanced Materials · doi:10.1002/adma.202206200 · Cited by 208
Self-citationThe microbial landscape of colorectal cancer
White, M. T., & Sears, C. L. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00973-4 · Cited by 161
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Kang, X., Lau, H. C.-H., & Yu, J. Q. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101478 · Cited by 197
Luo, Z.-W., Xia, K., Liu, Y.-W., Liu, J.-H., Rao, S.-S., Hu, X.-K., Chen, C.-Y., Xu, R., Wang, Z.-X., & Xie, H. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s304515 · Cited by 162
“Consistent with numerous studies showing the safety of bacterial EVs, our experiments also confirmed no notable toxic effects in immune-competent mice.(62,64,65) Further studies are needed to systematically observe and comprehensively evaluate the long-term effects and safety of Akk-EVs application for cancer therapy.”
Connecting Calcium-Based Nanomaterials and Cancer: From Diagnosis to Therapy
Bai, S., Lan, Y., Fu, S., Cheng, H., Lu, Z., & Liu, G. (2022) · Nano-Micro Letters · doi:10.1007/s40820-022-00894-6 · Cited by 175
Wu, S., Huang, Y., Yan, J., Li, Y., Wang, J., Yang, Y. Y., Yuan, P., & Ding, X. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202103442 · Cited by 165
Self-citationNanobiomaterial-based vaccination immunotherapy of cancer
Chen, F., Wang, Y., Gao, J., Saeed, M., Li, T., Wang, W., & Yu, H. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120709 · Cited by 174
Wang, J., Zhu, M., & Nie, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113974 · Cited by 153
Self-citationGuo, Q., Li, X., Zhou, W., Chu, Y., Chen, Q., Zhang, Y., Li, C., Chen, H., Liu, P., Zhao, Z., et al. (2021) · ACS Nano · doi:10.1021/acsnano.1c05613 · Cited by 154
Bacterial extracellular vesicles: Understanding biology promotes applications as nanopharmaceuticals
Jahromi, L. P., & Fuhrmann, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.03.012 · Cited by 147
Biomimetic and bioinspired nano‐platforms for cancer vaccine development
Feng, C., Tan, P., Nie, G., & Zhu, M. (2023) · Exploration · doi:10.1002/exp.20210263 · Cited by 158
Yin, N., Zhao, Y., Liu, C., Yang, Y., Wang, Z., Yu, W., Zhang, K., Zhang, Z., Liu, J., Zhang, Y., et al. (2022) · Advanced Materials · doi:10.1002/adma.202201322 · Cited by 134
Gut bacterial extracellular vesicles: important players in regulating intestinal microenvironment
Liang, X. H., Dai, N., Sheng, K., Lu, H., Wang, J., Chen, L., & Wang, Y. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2134689 · Cited by 142
“So far, a consensus mechanism underlying BEV biogenesis applicable to all bacteria has not been identified.32,33 BEVs secreted by gram-negative bacteria are also referred to as outer membrane vesicles (OMVs).34 Gut bacteria-derived extracellular vesicles (GBEVs) were first identified in the electron microscopic images…”
BackgroundInfluentialSelf-citationCell‐Based Delivery Systems: Emerging Carriers for Immunotherapy
Li, Z., Wang, Y., Ding, Y., Repp, L., Kwon, G. S., & Hu, Q. (2021) · Advanced Functional Materials · doi:10.1002/adfm.202100088 · Cited by 146
Emerging vaccine nanotechnology: From defense against infection to sniping cancer
Feng, C., Li, Y., Ferdows, B. E., Patel, D. N., Ouyang, J., Tang, Z., Kong, N., Chen, E., & Tao, W. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.021 · Cited by 140
Advances and applications of nanoparticles in cancer therapy
Huang, X., He, T., Liang, X., Xiang, Z., Liu, C., Zhou, S., Luo, R., Bai, L., Kou, X., Li, X., et al. (2024) · MedComm – Oncology · doi:10.1002/mog2.67 · Cited by 156
Su, X., Wang, H., Li, Q., & Chen, Z. (2025) · International Journal of Nanomedicine · doi:10.2147/ijn.s502591 · Cited by 139
“86,87 However, the intrinsic immunotoxicity associated with OMVs derived from bacteria has considerably impeded their clinical application.”
Bacterial extracellular vesicles and their novel therapeutic applications in health and cancer
Hosseini-Giv, N., Basas, A., Hicks, C., El-Omar, E. M., El‐Assaad, F., & Hosseini‐Beheshti, E. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.962216 · Cited by 132
“This method can also be applied in combination therapy and combined with other therapeutic agents (Qing et al., 2020).”
MethodProgress of engineered bacteria for tumor therapy
Fan, J.-X., Niu, M.-T., Qin, Y.-T., Sun, Y.-X., & Zhang, X.-Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114296 · Cited by 120
Fu, F., Wang, W., Wu, L., Wang, W., Huang, Z., Huang, Y., Wu, C., & Pan, X. (2023) · ACS Nano · doi:10.1021/acsnano.2c10830 · Cited by 130
Nanotechnology-empowered vaccine delivery for enhancing CD8+ T cells-mediated cellular immunity
Liu, G., Zhu, M., Zhao, X., & Nie, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113889 · Cited by 121
Long, Q., Zheng, P., Zheng, X. W., Li, W., Hua, L., Yang, Z., Huang, W., & Ma, Y. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114321 · Cited by 117
Customized materials-assisted microorganisms in tumor therapeutics
Chen, Q., Qiao, J., Liu, X., Zhang, C., & Zhang, X. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01571g · Cited by 110
Li, Y., Wu, J., Qiu, X., Dong, S., He, J., Liu, J., Xu, W., Huang, S. Q., Hu, X.-B., & Xiang, D. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.05.037 · Cited by 124
“M2-to-M1 polarization of macrophages for antitumor therapy [26], therefore facilitating targeted delivery of OMVs to the tumor site (Fig.”
BackgroundZhuang, W., Wang, Y., Yao, L., Zuo, L., Jiang, A., Wu, G., Nie, W., Huang, L., & Xie, H. (2022) · Nano Letters · doi:10.1021/acs.nanolett.2c01280 · Cited by 106
Bacterial membrane vesicles for vaccine applications
Krishnan, N., Kubiatowicz, L. J., Holay, M., Zhou, J., Fang, R. H., & Zhang, L. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114294 · Cited by 105
Bacterial nanotechnology as a paradigm in targeted cancer therapeutic delivery and immunotherapy
Gholami, A., Mohkam, M., Soleimanian, S., Sadraeian, M., & Lauto, A. (2024) · Microsystems & Nanoengineering · doi:10.1038/s41378-024-00743-z · Cited by 104
“They utilized membrane fusion technology, which depends on the fact that many cell membranes are structurally similar, to achieve the fusion of two natural bio-membranes 80 .”
BackgroundZhang, J., Fan, B., Cao, G., Huang, W., Jia, F., Nie, G., & Wang, H. (2022) · Advanced Materials · doi:10.1002/adma.202205950 · Cited by 95
Zai, W., Kang, L., Dong, T., Wang, H., Yin, L., Gan, S., Lai, W., Ding, Y., Hu, Y., & Wu, J. (2021) · ACS Nano · doi:10.1021/acsnano.1c07621 · Cited by 99
TME-Related Biomimetic Strategies Against Cancer
Peng, C., Xu, Y., Wu, J., Wu, D., Zhou, L., & Xia, X. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s441135 · Cited by 102
Liu, C., Yazdani, N., Moran, C. S., Salomon, C., Seneviratne, C. J., Ivanovski, S., & Han, P. (2024) · Acta Biomaterialia · doi:10.1016/j.actbio.2024.04.022 · Cited by 101
Chen, X., Li, P., Luo, B., Song, C. Q., Wu, M., Yao, Y., Wang, D., Li, X., Hu, B., He, S., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c05714 · Cited by 100
Zheng, T., Hao, H., Liu, Q., Li, J., Yao, Y., Liu, Y., Zhang, T., Zhang, Z., & Yi, H. (2023) · Nutrients · doi:10.3390/nu15224722 · Cited by 97
“For example, Biomineralized bacterial extracellular vesicles [37] could exert a positive impact on the host.”
BackgroundZheng, K., Feng, Y., Li, L., Kong, F., Gao, J., & Kong, X. (2024) · Theranostics · doi:10.7150/thno.85917 · Cited by 97
“Further, the native OMV-induced anti-tumor effect based on IFN-α was generally limited to tumor enlargement inhibition rather than tumor regression [35] (Figure 2D).”
BackgroundLi, Q., Zhang, X., Zhang, C., Zhang, Y., Niu, M., Chen, Z., Zhang, S., He, J., Chen, W., & Zhang, X.-Z. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c05148 · Cited by 92
Nano co-delivery of Plumbagin and Dihydrotanshinone I reverses immunosuppressive TME of liver cancer
Han, S., Bi, S., Guo, T., Sun, D., Zou, Y., Wang, L., Song, L., Chu, D., Liao, A., Song, X., et al. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.05.057 · Cited by 91
Bacterial Membrane Vesicles: Physiological Roles, Infection Immunology, and Applications
Gan, Y., Zhao, G., Wang, Z., Zhang, X., Wu, M. X., & Lu, M. (2023) · Advanced Science · doi:10.1002/advs.202301357 · Cited by 89
Bai, Y., Zhao, J., Zhang, L., Wang, S., Hua, J., Zhao, S., & Liang, H. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202102759 · Cited by 85
Self-citationLiang, J., Zhu, F., Cheng, K., Ma, N., Ma, X., Feng, Q., Xu, C., Gao, X., Wang, X., Shi, J., et al. (2023) · Advanced Materials · doi:10.1002/adma.202306158 · Cited by 84
Self-citationTargeting the tumor microenvironment with biomaterials for enhanced immunotherapeutic efficacy
Feng, Y., Tang, Q., Wang, B., Yang, Q., Zhang, Y., Lei, L., & Li, S. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-03005-2 · Cited by 83
“Notably, inorganic NPs such as calcium carbonate (CaCO 3 ) [172, 173], calcium phosphate (CaP) [174], and MnO 2 [172], which exhibit solubility in acidic conditions, have emerged as promising candidates for pH-responsive cancer therapies.”
Engineered bacterial extracellular vesicles for osteoporosis therapy
Liu, H., Li, M., Zhang, T., Liu, X., Zhang, H., Geng, Z., & Su, J. (2022) · Chemical Engineering Journal · doi:10.1016/j.cej.2022.138309 · Cited by 82
Bacteria-based immunotherapy for cancer: a systematic review of preclinical studies
Zhou, M., Tang, Y., Xu, W., Hao, X., Li, Y., Huang, S. Q., Xiang, D., & Wu, J. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1140463 · Cited by 92
Enhancing therapeutic performance of personalized cancer vaccine via delivery vectors
Ye, T., Li, F., Ma, G., & Wei, W. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113927 · Cited by 76
Self-citationTumor Diagnosis and Therapy Mediated by Metal Phosphorus‐Based Nanomaterials
Liu, Y., Wang, Y., Song, S., & Zhang, H. (2021) · Advanced Materials · doi:10.1002/adma.202103936 · Cited by 76
Liu, X., Xiao, C., & Xiao, K. (2023) · Journal of Nanobiotechnology · doi:10.1186/s12951-023-02064-1 · Cited by 78
“In addition to functional proteins, genetic engineering techniques can also introduce noncoding RNA sequences into EBPs, such as miRNA or small interfering RNA (siRNA) [28].”
BackgroundZheng, P., He, J., Fu, Y., Yang, Y., Li, S., Duan, B., Yang, Y., Hu, Y., Yang, Z., Wang, M., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c06987 · Cited by 77
Application of lipid nanovesicle drug delivery system in cancer immunotherapy
Ding, Y., Wang, L., Li, H., Miao, F., Zhang, Z., Hu, C., Yu, W., Tang, Q., & Shao, G. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01429-2 · Cited by 75
“In the slightly acidic microenvironment of the tumor, the calcium phosphate shell is dissolved, which can neutralize the acidic TME but can also expose OMVs to the tumor tissue and stimulate the local immune response [101].”
BackgroundPhysical Disruption of Solid Tumors by Immunostimulatory Microrobots Enhances Antitumor Immunity
Zhou, J., Karshalev, E., Mundaca‐Uribe, R., Esteban‐Fernández de Ávila, B., Krishnan, N., Xiao, C., Ventura, C. J., Gong, H., Zhang, Q., Gao, W., et al. (2021) · Advanced Materials · doi:10.1002/adma.202103505 · Cited by 68
Self-citationChen, L., Ma, X., Liu, W., Hu, Q., & Yang, H. (2023) · Nano Letters · doi:10.1021/acs.nanolett.3c02728 · Cited by 71
Bacterial biomineralization of heavy metals and its influencing factors for metal bioremediation
Mallick, S., Pradhan, T., & Das, S. (2025) · Journal of Environmental Management · doi:10.1016/j.jenvman.2024.123977 · Cited by 71
Advances in Engineered Macrophages: A New Frontier in Cancer Immunotherapy
Yang, S., Wang, Y., Jia, J., Fang, Y., Yang, Y., Yuan, W., & Hu, J. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-06616-7 · Cited by 74
“Cancer immunotherapy can block immunosuppressive TME through immune checkpoint inhibitors, such as anti-PD 1/PD-L1 therapy [103].”
BackgroundOpportunities and challenges of bacterial extracellular vesicles in regenerative medicine
Guo, J., Huang, Z., Wang, Q., Wang, M., Ming, Y., Chen, W., Huang, Y., Tang, Z., Huang, M., Liu, H., et al. (2025) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02935-1 · Cited by 69
Allemailem, K. S. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s338272 · Cited by 67
Emerging role of bacterial outer membrane vesicle in gastrointestinal tract
Tian, C., Yang, M., Xu, H., Zhu, M., Zhang, Y., Yao, J., Wang, L., Liang, Y.-J., & Li, D. (2023) · Gut Pathogens · doi:10.1186/s13099-023-00543-2 · Cited by 67
Immunomodulatory roles and novel applications of bacterial membrane vesicles
Gilmore, W. J., Johnston, E. L., Zavan, L., Bitto, N. J., & Kaparakis‐Liaskos, M. (2021) · Molecular Immunology · doi:10.1016/j.molimm.2021.02.027 · Cited by 66
Engineering bacterial membrane nanovesicles for improved therapies in infectious diseases and cancer
Gao, J., Su, Y., & Wang, Z. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114340 · Cited by 67
The quest for nanoparticle-powered vaccines in cancer immunotherapy
Sun, Z., Zhao, H., Ma, L., Shi, Y., Ji, M., Sun, X., Ma, D., Zhou, W., Huang, T., & Zhang, D. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02311-z · Cited by 72
Bacteria extracellular vesicle as nanopharmaceuticals for versatile biomedical potential
Ho, M. Y., Liu, S., & Xing, B. (2024) · Nano Convergence · doi:10.1186/s40580-024-00434-5 · Cited by 64
Manling, W., Wang, M., Jia, H., & Wu, P. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2104404 · Cited by 63
Bacterial outer membrane vesicle-based cancer nanovaccines
Gao, X., Feng, Q., Wang, J., & Zhao, X. (2022) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2022.0452 · Cited by 62
Self-citationLuo, Z., Cheng, X., Feng, B., Fan, D., Liu, X., Xie, R., Luo, T., Wegner, S. V., Ma, D., Chen, F., et al. (2024) · Advanced Science · doi:10.1002/advs.202400049 · Cited by 67
Sun, L., Gao, W., Liu, J., Wang, J., Li, L., Yu, H., & Xu, Z. P. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c18960 · Cited by 60
Self-citationManipulating calcium homeostasis with nanoplatforms for enhanced cancer therapy
Feng, Y., Wang, J., Cao, J.-M., Cao, F., & Chen, X. S. (2023) · Exploration · doi:10.1002/exp.20230019 · Cited by 60
Self-citationIntratumoral Microbiota as a Target for Advanced Cancer Therapeutics
Peng, F., Hu, M., Su, Z., Hu, L., Guo, L., & Yang, K. (2024) · Advanced Materials · doi:10.1002/adma.202405331 · Cited by 61
Zhang, J., Wan, S., Zhou, H., Du, J., Li, Y., Zhu, H., Weng, L., Ding, X., & Wang, L. (2024) · ACS Nano · doi:10.1021/acsnano.3c13194 · Cited by 61
Ma, S., Li, D., Jia, X., Xu, W., Ding, G., He, J., & Wang, J. (2024) · Advanced Functional Materials · doi:10.1002/adfm.202402692 · Cited by 59
Self-citationExtracellular vesicles: From large-scale production and engineering to clinical applications
Wang, Y., Xiong, J., Ouyang, K., Ling, M., Luo, J., Sun, J., Xi, Q., Chen, T., & Zhang, Y. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314251319474 · Cited by 61
Chen, W., Song, Y., Bai, S., He, C., Guo, Z., Zhu, Y., Zhang, Z., & Sun, X. (2023) · ACS Nano · doi:10.1021/acsnano.3c00363 · Cited by 60
Harnessing Engineered Immune Cells and Bacteria as Drug Carriers for Cancer Immunotherapy
Jiang, J., Huang, Y., Zeng, Z., & Zhao, C. (2023) · ACS Nano · doi:10.1021/acsnano.2c07607 · Cited by 59
Engineered bacterial extracellular vesicles for central nervous system diseases
Ji, N., Wang, F., Wang, M., Zhang, W. C., Liu, H., & Su, J. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.10.027 · Cited by 58
Çelik, P. A., Gover, K. E., Barut, D., Enuh, B. M., Amasya, G., Şengel-Türk, C. T., Derkuş, B., & Çabuk, A. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15041052 · Cited by 59
Extracellular vesicles hybrid plasmid-loaded lipid nanovesicles for synergistic cancer immunotherapy
Tong, Q., Li, K., Huang, F., Dai, Y., Zhang, T., Muaibati, M., Abasi, A., & Huang, X. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100845 · Cited by 62
“Since Escherichia coli-derived OMVs were previously found to cause sever toxicity in vivo [35], DH5 α -OMV was chosen as the positive control.”
MethodBacteria-based bioactive materials for cancer imaging and therapy
Chen, Y., Li, Z.-H., Zeng, X., & Zhang, X. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114696 · Cited by 54
Qin, H., Chen, Y., Wang, Z., Li, N., Sun, Q., Lin, Y., Qiu, W., Qin, Y., Chen, L., Chen, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40851-4 · Cited by 54
“Arti fi cial nanomaterials can be exploited to integrate immunomodulating molecules and deliver therapeutics in vivo, however, great challenges remain to more precisely control the types and amounts of the loaded cargoes 14 .”
Lu, J., Song, J., Zhang, P., Huang, Y., Lu, X., Dai, H., & Xi, J. (2023) · ACS Nano · doi:10.1021/acsnano.3c05563 · Cited by 54
Nanomaterial-based delivery vehicles for therapeutic cancer vaccine development
Liang, J., & Zhao, X. (2021) · Cancer Biology and Medicine · doi:10.20892/j.issn.2095-3941.2021.0004 · Cited by 56
Wang, J., Liang, S., Chen, S., Ma, T., Chen, M., Niu, C., Leng, Y., & Wang, L. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02619-w · Cited by 53
“E. coli strains are commonly used for producing OMVs in tumor immune treatment [28, 34, 39].”
Self-citationEffah, C. Y., Ding, X., Drokow, E. K., Li, X., Tong, R., & Sun, T. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1296061 · Cited by 53
Xia, L., Zhu, X., Wang, Y., & Lü, S. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217123 · Cited by 56
Zhu, C., Liu, C., Wu, Q., Sheng, T., Zhou, R., Ren, E., Zhang, R., Zhao, Z., Shi, J., Shen, X., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02028-3 · Cited by 55
Metal-Phenolic Outer Membrane Vesicles for Cancer Radioimmunotherapy
Zhao, C., Pan, Y., Cao, L., Tang, Y., Chen, X. S., Zhao, X., & Rao, L. (2025) · Journal of the American Chemical Society · doi:10.1021/jacs.5c02774 · Cited by 52
Wang, Y., Dong, A., Man, J., Chen, H., Shen, W., Wang, L., Yang, H., Hu, L., & Yang, K. (2025) · Advanced Materials · doi:10.1002/adma.202417920 · Cited by 59
Advances of bacteria-based delivery systems for modulating tumor microenvironment
Li, S., Yue, H., Wang, S., Li, X., Wang, X., Guo, P., Ma, G., & Wei, W. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114444 · Cited by 51
Self-citationBacterial Extracellular Vesicles: Bridging Pathogen Biology and Therapeutic Innovation
Moghaddam, Z. S., Dehghan, A., Halimi, S., Najafi, F., Nokhostin, A., Naeini, A. E., Akbarzadeh, I., & Ren, Q. (2025) · Acta Biomaterialia · doi:10.1016/j.actbio.2025.05.028 · Cited by 51
Extracellular Vesicle‐Based mRNA Therapeutics and Vaccines
Li, Q., Xing, H., Naeem, A., Zhang, K., Zheng, A., Huang, Y., & Lu, M. (2025) · Exploration · doi:10.1002/exp.20240109 · Cited by 64
“However, the investigation into their mRNA profiles warrants further exploration [124].”
Hua, L., Yang, Z., Li, W., Zhang, Q., Ren, Z., Ye, C., Zheng, X. W., Li, D., Long, Q., Bai, H., et al. (2021) · Advanced Materials · doi:10.1002/adma.202103923 · Cited by 48
Tumor-targeted nano-delivery system of therapeutic RNA
Wang, M., Zhao, J., Jiang, H., & Wang, X. (2022) · Materials Horizons · doi:10.1039/d1mh01969d · Cited by 47
Plant-derived nanovesicles as an emerging platform for cancer therapy
Liu, H., Luo, G., & Shang, Z. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.033 · Cited by 46
Zong, R. L., Ruan, H., Liu, C., Fan, S., & Li, J. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15102490 · Cited by 46
“A recent study [124] found that OMVs extracted from E. coli BL21 had a remarkable suppression on tumor growth.”
BackgroundBacterial Extracellular Vesicles in Gastrointestinal Tract Cancer: An Unexplored Territory
Amatya, S. B., Salmi, S., Kainulainen, V., Karihtala, P., & Reunanen, J. (2021) · Cancers · doi:10.3390/cancers13215450 · Cited by 45
“Strong fluorescence signals were observed at tumor sites even after 24 h of final injection indicating efficient accumulation of the vesicles in the tumor site [77].”
BackgroundMethodInfluentialNanotechnology-Employed Bacteria-Based Delivery Strategy for Enhanced Anticancer Therapy
Ye, Z., Liang, L., Lu, H., Shen, Y., Zhou, W., & Li, Y. (2021) · International Journal of Nanomedicine · doi:10.2147/ijn.s329855 · Cited by 50
“Moreover, they further doped folic acid into CaP shells to enhanced the tumor targeting.(85) Referred to the similar structure of various cell membranes, membrane fusion technology was used to achieve the fusion of two natural biomembranes, even the fusion of MVs with liposomes.”
MethodLi, N., Zhang, Y., Han, M., Liu, T., Wu, J., Xiong, Y., Fan, Y., Ye, F., Bing, J., Zhang, Y., et al. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2465-x · Cited by 44
“Then, the OVA-APS nanocomposites were encapsulated by a thin film by CaP via the surface precipitation method to obtain core-shell-structured NVs (APS-NVs: APS HMw and APS HMw NVs), and the preparation method is shown in Figure 1A (Qing et al., 2020).”
Yao, W., Liu, W., Su, F., Wang, J., Li, H., Sun, M., Ma, Y., Xu, Y., Li, D., Wang, Y., et al. (2024) · Journal of the American Chemical Society · doi:10.1021/jacs.4c04840 · Cited by 44
Self-citation
Metadata
- Authors
- Qing, S., Lyu, C., Zhu, L., Pan, C., Wang, S., Li, F., Wang, J., Yue, H., Gao, X., Jia, R., Wei, W., & Ma, G.
- Affiliations
- Chinese Academy of Sciences (CN)
- State Key Laboratory of Pathogen and Biosecurity Beijing Institute of Biotechnology No. 20 Dongda Street Beijing 100071 P. R. China
- Shanghai Jiao Tong University (CN)
- Corresponding author
- Wei, Wei
- Ma, Guanghui
- ORCID
- Venue
- Advanced Materials
- Publisher
- Wiley
- Published
- 2020-10-05
- Volume
- 32
- Issue
- 47
- Pages
- e2002085-e2002085
- ISSN
- 0935-9648 (ISSN-L)
- 1521-4095
- OpenAlex
- W3090405704
- Cited by
- 309
- References
- 48
- Citations by year
- 2026: 31 · 2025: 72 · 2024: 75 · 2023: 56 · 2022: 42 · 2021: 31 · 2020: 1
- FWCI
- 10.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Advanced Materials (publishedVersion)
- PubMed (publishedVersion)
- Institute of Process Engineering, CAS Institutional Repository (submittedVersion)
- Funders
- National Natural Science Foundation of China (21821005)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Nanoplatforms for cancer theranostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- bacterial outer membrane vesicles, biomineralization, tumor microenvironment reprogramming, immunosuppression, M2 to M1 macrophage polarization, pH-responsive drug delivery, folic acid, photosensitizers, combination therapy, intravenous injection
- MeSH terms
- Extracellular Vesicles, Biomineralization, Bacterial Outer Membrane, Adjuvants, Immunologic, Immunotherapy, Macrophages, Safety, Tumor Microenvironment
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.